Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) have been given an average rating of “Moderate Buy” by the ten brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, one has given a buy recommendation and three have issued a strong buy recommendation on the company.
Several research analysts recently commented on the stock. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th.
View Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Trading Down 1.4 %
Reckitt Benckiser Group Cuts Dividend
The company also recently announced a dividend, which was paid on Monday, September 23rd. Shareholders of record on Monday, August 5th were issued a $0.1915 dividend. The ex-dividend date of this dividend was Monday, August 5th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- When to Sell a Stock for Profit or Loss
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- About the Markup Calculator
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Using the MarketBeat Dividend Yield Calculator
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.